Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Campbell Soup
CPB
$6.8B
| $85M | 0.05% |
1,711,791
+846,513
| +98% | +$42M |
|
352
Paylocity
PCTY
$7.43B
| $84.9M | 0.05% |
582,206
-46,328
| -7% | -$5.39M |
|
353
NeoGenomics
NEO
$1.74B
| $84.9M | 0.05% |
2,740,970
-53,299
| -2% | -$1.48M |
|
354
HealthEquity
HQY
$8.46B
| $84.6M | 0.05% |
1,442,314
-84,343
| -6% | -$4.66M |
|
355
Lumentum
LITE
$50.7B
| $84.5M | 0.05% |
+1,038,045
| New | +$79.1M |
|
356
iShares Core US Aggregate Bond ETF
AGG
$138B
| $83.5M | 0.05% |
706,607
-67,070
| -9% | -$7.85M |
|
357
Wendy's
WEN
$1.46B
| $83.5M | 0.05% |
3,834,005
-339,772
| -8% | -$6.75M |
|
|
MYOV
358
DELISTED
Myovant Sciences Ltd.
MYOV
| $83.1M | 0.05% |
4,031,200
-682,289
| -14% | -$9.28M |
|
359
Gates Industrial Corporation Ltd.
GTES
$6.69B
| $82.9M | 0.05% |
8,067,788
-387,648
| -5% | -$3.52M |
|
360
Darden Restaurants
DRI
$23.7B
| $82.3M | 0.05% |
1,086,601
+199,664
| +23% | +$14.2M |
|
361
Itron
ITRI
$4.75B
| $82.1M | 0.05% |
1,239,324
+4,080
| +0.3% | +$260K |
|
|
EGRX
362
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $81.9M | 0.05% |
1,706,644
-52,850
| -3% | -$2.64M |
|
363
Mercado Libre
MELI
$94.4B
| $81.7M | 0.05% |
82,931
-12,484
| -13% | -$9.36M |
|
364
National Vision
EYE
$1.75B
| $81.5M | 0.05% |
2,671,539
+358,152
| +15% | +$9.4M |
|
|
TIF
365
DELISTED
Tiffany & Co.
TIF
| $81.4M | 0.05% |
667,782
+363,455
| +119% | +$45.5M |
|
366
Lamb Weston
LW
$7.51B
| $79.8M | 0.04% |
1,248,071
-458,467
| -27% | -$27.7M |
|
367
Prosperity Bancshares
PB
$8.82B
| $79.4M | 0.04% |
1,337,603
+263,234
| +25% | +$15.2M |
|
368
ACI Worldwide
ACIW
$6.1B
| $79.2M | 0.04% |
2,934,008
+30,606
| +1% | +$800K |
|
|
SAIL
369
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $78.8M | 0.04% |
2,977,453
+771
| +0% | +$15.9K |
|
|
JBTM
370
JBT Marel
JBTM
$7.59B
| $78.8M | 0.04% |
916,071
+13,607
| +2% | +$1.06M |
|
371
Avnet
AVT
$7.07B
| $78.6M | 0.04% |
2,820,251
-1,037,169
| -27% | -$28.8M |
|
372
Vail Resorts
MTN
$5.6B
| $78.6M | 0.04% |
431,723
+97,626
| +29% | +$17.1M |
|
373
Chevron
CVX
$374B
| $78.5M | 0.04% |
879,776
-852,471
| -49% | -$76.3M |
|
374
3M
MMM
$94.1B
| $78.5M | 0.04% |
601,635
+299,835
| +99% | +$37.8M |
|
375
BioNTech
BNTX
$23.4B
| $78M | 0.04% |
+1,169,133
| New | +$58.4M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.